Dr. Falk Pharma GmbH (Responsible for release of final product batches)

Ukraine

All drugs from this manufacturer

  • BUDENEFALK

    The drug is used for the treatment of active ulcerative colitis limited to the rectum and sigmoid colon.

    Dosage form: foam, rectal

    Active substance Dosage
    budesonide 2 mg per dose

    ATC: A07EA06

  • The drug is used to treat Crohn's disease (to achieve remission), microscopic colitis, and autoimmune hepatitis.

    Dosage form: capsules, hard with enteric-coated granules

    Active substance Dosage
    budesonide 3 mg

    ATC: A07EA06

  • The preparation is used for bowel cleansing before undergoing colonoscopy.

    Dosage form: powder for oral solution

    Active substance Dosage
    macrogol 3350 52500 g
    sodium chloride 1400 g
    sodium bicarbonate 0.715 g
    potassium chloride 0.185 g

    ATC: A06AD65

  • The drug is used to treat exacerbations of ulcerative colitis limited to the rectum (ulcerative proctitis).

    Dosage form: suppositories, rectal

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02